Pollack A - Search Results

1

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial.

Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, von Eschenbach AC, Kuban DA, Rosen I. Pollack A, et al. Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1097-105. doi: 10.1016/s0360-3016(02)02829-8. Int J Radiat Oncol Biol Phys. 2002. PMID: 12128107 Clinical Trial.

2

Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy.

Cowen D, Troncoso P, Khoo VS, Zagars GK, von Eschenbach AC, Meistrich ML, Pollack A. Cowen D, et al. Among authors: pollack a. Clin Cancer Res. 2002 May;8(5):1148-54. Clin Cancer Res. 2002. PMID: 12006531

3

Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer.

Pollack A, Kuban DA, Zagars GK. Pollack A, et al. Urology. 2002 Sep;60(3 Suppl 1):22-30; discussion 30-1. doi: 10.1016/s0090-4295(02)01564-9. Urology. 2002. PMID: 12231041 Review.

4

Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial.

Pollack A, Zagars GK, Antolak JA, Kuban DA, Rosen II. Pollack A, et al. Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):677-85. doi: 10.1016/s0360-3016(02)02977-2. Int J Radiat Oncol Biol Phys. 2002. PMID: 12377318 Clinical Trial.

5

Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer.

Rosser CJ, Kuban DA, Levy LB, Chichakli R, Pollack A, Lee AK, Pisters LL. Rosser CJ, et al. Among authors: pollack a. J Urol. 2002 Nov;168(5):2001-5. doi: 10.1016/S0022-5347(05)64282-6. J Urol. 2002. PMID: 12394695

6

Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer.

Huang EH, Pollack A, Levy L, Starkschall G, Dong L, Rosen I, Kuban DA. Huang EH, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1314-21. doi: 10.1016/s0360-3016(02)03742-2. Int J Radiat Oncol Biol Phys. 2002. PMID: 12459352

7

Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x.

Pollack A, Cowen D, Troncoso P, Zagars GK, von Eschenbach AC, Meistrich ML, McDonnell T. Pollack A, et al. Cancer. 2003 Apr 1;97(7):1630-8. doi: 10.1002/cncr.11230. Cancer. 2003. PMID: 12655519 Free article.

8

Experience of ultrasound-based daily prostate localization.

Chandra A, Dong L, Huang E, Kuban DA, O'Neill L, Rosen I, Pollack A. Chandra A, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):436-47. doi: 10.1016/s0360-3016(02)04612-6. Int J Radiat Oncol Biol Phys. 2003. PMID: 12738318

9

Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer.

Lee HK, D'Souza WD, Yamal JM, Pollack A, Lee AK, Palmer MB, Kuban DA. Lee HK, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):355-61. doi: 10.1016/s0360-3016(03)00583-2. Int J Radiat Oncol Biol Phys. 2003. PMID: 12957245

10

Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study.

Little DJ, Kuban DA, Levy LB, Zagars GK, Pollack A. Little DJ, et al. Among authors: pollack a. Urology. 2003 Oct;62(4):707-13. doi: 10.1016/s0090-4295(03)00504-1. Urology. 2003. PMID: 14550448 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

961 results

Search Page

Filters